SCHEMBL408846

SCHEMBL408846

CC(C)(C)C(=O)CS

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23187 0.76
SCHEMBL4398751 0.75
SCHEMBL4682863 0.73
SCHEMBL755487 0.72 KMT2A (0.39)
SCHEMBL93393 0.72 KMT2A (0.39)
SCHEMBL4837194 0.72 KMT2A (0.39)
SCHEMBL2528459 0.71
SCHEMBL6910342 0.69 KMT2A (0.37)
SCHEMBL9566006 0.69 KMT2A (0.37)
SCHEMBL21405194 0.69 KMT2A (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11732259-B2 Peptide oligonucleotide conjugates SAREPTA THERAPEUTICS, INC. (US) 2023-08-22 US disclosed
US-20180223278-A1 Functionally-Modified Oligonucleotides And Subunits Thereof JPMORGAN CHASE BANK, N.A. AS ADMINISTRATIVE AGENT 2018-08-09 US disclosed
US-10017763-B2 dsRNA molecules comprising oligonucleotide analogs having modified intersubunit linkages and/or terminal groups SAREPTA THERAPEUTICS, INC. (US) 2018-07-10 US disclosed
US-20180170876-A1 NOVEL HISTONE DEACETYLASE INHIBITORS KARUS THERAPEUTICS LIMITED (GB) 2018-06-21 US disclosed
US-20180092938-A1 OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA JPMORGAN CHASE BANK, N.A. AS ADMINISTRATIVE AGENT 2018-04-05 US disclosed
US-20180086750-A1 NOVEL HISTONE DEACETYLASE INHIBITORS AND THEIR USE IN THERAPY KARUS THERAPEUTICS LIMITED (GB) 2018-03-29 US disclosed
US-9862685-B2 Histone deacetylase inhibitors KARUS THERAPEUTICS LIMITED (GB) 2018-01-09 US disclosed
US-9862946-B2 Peptide oligonucleotide conjugates SAREPTA THERAPEUTICS, INC. (US) 2018-01-09 US disclosed
US-9833468-B2 Methods for treating progeroid laminopathies using oligonucleotide analogues targeting human LMNA SAREPTA THERAPEUTICS, INC. (US) 2017-12-05 US disclosed
US-20170313712-A1 DIHETEROARYL HISTONE DEACETYLASE INHIBITORS AND THEIR USE IN THERAPY KARUS THERAPEUTICS LIMITED (GB) 2017-11-02 US disclosed
US-7250514-B1 Histone deacetylase inhibitors TAKEDA SAN DIEGO, INC. (US) 2007-07-31 US disclosed
US-7169801-B2 Histone deacetylase inhibitors TAKEDA SAN DIEGO, INC. (US) 2007-01-30 US disclosed
US-7169801-B2 Histone deacetylase inhibitors TAKEDA SAN DIEGO, INC. (US) 2007-01-30 US disclosed
EP-1280419-A4 FURFURYL PROPYL DISULFIDE AS A FLAVORING AGENT AND METHODS FOR PREPARING AND USING SAME BUSH BOAKE ALLEN INC (US) 2005-01-19 EP disclosed
US-20040266769-A1 Histone deacetylase inhibitors SYRRX, INC. 2004-12-30 US disclosed
US-6824805-B2 ADMIXING INGESTIBLE VEHICLE (MEAT, DAIRY, AND BEVERAGE PRODUCTS) WITH ORGANOLEPTIC PURIFIED FURFURYL PROPYL DISULFIDE FORMED BY REACTING SODIUM FURFURYLTHIOLATE WITH SODIUM PROPYLTHIOSULFATE BUSH BOAKE ALLEN LTD. 2004-11-30 US disclosed
EP-1280419-A1 FURFURYL PROPYL DISULFIDE AS A FLAVORING AGENT AND METHODS FOR PREPARING AND USING SAME Bush Boake Allen Inc. (US) 2003-02-05 EP disclosed
US-20020110628-A1 Furfuryl propyl disulfide as a flavoring agent and methods for preparing and using same BUSH BOAKE ALLEN INC. 2002-08-15 US disclosed
WO-2001084959-A1 FURFURYL PROPYL DISULFIDE AS A FLAVORING AGENT AND METHODS FOR PREPARING AND USING SAME BUSH BOAKE ALLEN INC. (US) 2001-11-15 WO disclosed
US-3985907-A Novel 3-furyl beta oxoalkyl sulfides, processes for producing same and methods for using same for altering the organoleptic properties of foodstuffs INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 1976-10-12 US disclosed